| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2023 | Apr 24, 2023 | Genprex, Inc. | EVP GC Chief Strategy Officer | Buy | 86.3 | +20,000 | 8.16% | ✗ | $21.5K |
| Feb 5, 2015 | Feb 6, 2015 | LISATA THERAPEUTICS, INC. | General Counsel | Sell | 91.3 | +17,904 | 36.27% | ✗ | $42.8K |